Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients

Atherosclerosis

Volumn 147, Issue 2, 1999, Pages 411-413

  Constans, Joël ^a   Blann, Andrew D ^b   Resplandy, François ^c   Parrot, Françoise ^d   Seigneur, Martine ^c   Renard, Martine ^c   Amiral, Jean ^e   Guérin, Viviane ^c   Boisseau, Michel R ^c   Conri, Claude ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

^b Carnegie Laboratory of Physics   (United Kingdom)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d HÔPITAL PELLEGRIN   (France)

^e Serbio   (France)

Author keywords

Endothelium; Hyperhomocysteinaemia; Methionine; von Willebrand factor

Indexed keywords

METHIONINE; PADGEM PROTEIN; THROMBOMODULIN; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM LESION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; THROMBOCYTE DYSFUNCTION; VEIN OCCLUSION;

EID: 0032760624     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00260-9     Document Type: Article

References (8)

1. Stein J.H., McBride P.E. Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment. Arch. Intern. Med. 158:1998;1301-1306.
2. Bellamy M.F., Mc Dowell I.F., Ramsey M.W., Brownlee M., Bones C., Newcombe R.G. et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation. 3:1998;1848-1852.
3. Van den Berg M., Boers G.H.J., Franken D.G., Blom H.J., Van Kamp G.J., Jakobs C. et al. Hyperhomocysteinaemia and endothelial cell dysfunction in young patients with peripheral arterial occlusive disease. Eur. J. Clin. Invest. 25:1995;176-181.
4. Seigneur M., Dufoucq P., Conri C., Constans J., Mercié P., Pruvost A. et al. Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb. Res. 71:1993;423-431.
5. Blann A.D., Taberner D.A. A reliable marker of endothelial dysfunction: does it exist? Br. J. Haematol. 90:1995;244-248.
6. Drew A.F., Davenport P., Apostopoulos J., Tipping P.G. Tissue factor pathway inhibitor expression in atherosclerosis. Lab. Invest. 77:1997;291-298.
7. Blann A.D., Lip G.Y.H. Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis. 128:1997;135-138.
8. Brattstrom L., Israelsson B., Lindegarde F., Hultberg B. Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocysteinuria due to cystathionine β-synthase deficiency. Metabolism. 37:1988;175-178.